HUC2-676

N/A

Report date: 2025/12/26 14:28:43
NME

Base Information

Drug NameHUC2-676
Drug Alias NameSaxenda-based low-molecular-weight synthetic peptide(Huons Global Co Ltd)Saxenda-based synthetic peptide(Huons Global Co Ltd)HUC2-676HUC2676
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHuons Global Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuons Global Co LtdHuons Co Ltd
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A